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In this study, a fixation protocol using a 10% neutral buffered formalin (FA) solution 
and another protocol using a methanol (MeOH) solution were compared for detec-
tion of ion channels, Kv1.5, Kv4.2, Cav1.2, Kir6.2, Nav1.5 and Nav1.1 in rat myocytes 
by immunolabelling. Kv1.5 and Kv4.2 at intercalated discs and Cav1.2 at transverse 
tubules were not detected by FA but were detected by MeOH. Kir6.2 at transverse 
tubules and Nav1.5 at sarcolemma were detected by FA but not by MeOH. It is sug-
gested that both FA and MeOH fixation protocols should be used for the detection 
of cardiac ion channels by immunolabelling. (Folia Morphol 2015; 74, 2: 258–261)
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INTRODUCTION
Ion channels are pore-forming membrane proteins 
that span the lipid bilayer to allow a highly selective 
pathway into the cell [10]. The opening of ion chan-
nels allows the movement of ions across the cell 
membrane and can lead to a depolarisation of the 
cell from its negative resting membrane potential. The 
cardiac action potential consists of distinct phases of 
depolarisation and repolarisation brought about by 
the opening and closing of specific ion channels. The 
cloning and sequencing of ion channel proteins has 
allowed the investigation of cardiac ion channels at 
the molecular level [10]. Immunolabelling of ion chan-
nels in the heart is one of the most powerful tools for 
understanding their localisation within myocytes [2]. 
Despite the importance of immunolabelling, however, 
ion channel proteins in cardiac myocytes are someti-
mes difficult to detect using the immunofluorescence 
labelling technique.
The initial fixation of the tissue is an essential 
step in the immunolabelling protocol. The optimal 
fixation conditions for immunolabelling are a balan-
ce between the preservation of tissue morphology, 
the immobilisation of antigens, the preservation of 
antigen immunoreactivity, and the adequate pene-
trability of tissue by reagents [5]. The fixation of the 
tissue often leads to the introduction of artefacts 
[4], alterations in the chemical composition of the 
tissue, and physical changes in cellular and extracel-
lular constituents. Two common types of fixatives 
are cross-linkers and coagulants. Cross-link fixati-
ves such as formaldehyde, paraformaldehyde and 
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glutaraldehyde are the most commonly used fixatives 
for immunolabelling because of their high degree of 
tissue/cell penetration and good morphological preser-
vation [4]. The mechanism of fixation by cross-linkers 
is to form methylene bridges (-CH2-) between lysine 
and glutamine amino acids on protein chains, which 
leads to the immobilisation of the proteins [7]. The 
simplest cross-linker, formaldehyde (CH2O), is present 
in a hydrated form, methylene glycol (OH-CH2-OH), in 
solution. Condensing of the methylol group (CH2OH) 
with another compound containing active hydrogen 
ions leads to the production of the cross-links. The 
most common formaldehyde-based fixative is neutral 
buffered formalin (FA) solution, which was used in this 
study and is referred to here as FA (formalin is an aqueo-
us solution of formaldehyde). Examples of coagulant 
fixatives are acetone and alcohols such as ethanol and 
methanol (MeOH) [13]. Because alcohols fix through 
coagulation without forming additive compounds, they 
permit good antibody penetration and do not block 
immunoreactive determinants [13]. They are particularly 
useful for surface membrane antigens, which often 
display carbohydrate-containing epitopes; however, 
conformational changes can occur. Acetone is an ex-
cellent preservative of immunoreactive sites, leaving 
most sites intact, but as it is also a very poor penetrator, 
fixation is not complete and extended incubation may 
result in chromatolysis and membrane loss [4].
FA is the most commonly used fixative for detec-
ting ion channel proteins in cardiac myocytes using 
immunolabelling techniques, but the effects of coa-
gulants on cardiac myocytes are not fully understood. 
The purpose of the present study was to compare 
fixation with FA and fixation with MeOH to obtain 




All chemicals were purchased from Sigma-Aldrich 
Co. (St. Louis, MO), unless otherwise specified. All 
primary antibodies (immunoglobulin G [IgG]) were 
raised against intracellular epitopes. The primary IgGs 
investigated in this study were polyclonal IgGs raised 
against ion channels (Alomone Labs Ltd., Jerusalem, 
Israel) (Table 1). Secondary IgGs conjugated to fluore-
scein isothiocyanate (FITC) were purchased from Che-
micon International Inc. (Temecula, CA). All IgGs were 
diluted to 1 in 100 in phosphate buffered saline (PBS) 
containing 1% bovine serum albumin (BSA) before use.
Ventricular myocyte preparation
Sprague-Dawley male rats (300–800 g) were killed 
by stunning and cervical dislocation in accordance 
with the UK Animals (Scientific Procedures) Act 1986. 
Ventricular myocytes were enzymatically isolated and 
prepared as described previously [12]. After isolation, 
ventricular myocytes were suspended in Tyrode solu-
tion (in mM: NaCl, 130; KCl, 5.4; MgCl2, 1.4; CaCl2, 
0.5; NaH2PO4, 0.4; glucose, 10; taurine, 20; creatine, 
10; HEPES, 5; pH 7.3 with NaOH), placed onto Super-
-frost Plus slides, and left at room temperature for 
30 min for the cells to attach to the glass slides.
FA fixation protocol
Myocytes were incubated with FA (a phosphate 
buffered 10% formalin [approximately 4% formal-
dehyde] solution, pH 6.8–7.2) for 30 min at room 
temperature as previously described [2], followed by 
0.1% Triton X-100 in PBS for 30 min to permeabilise 
the cell membrane.
MeOH fixation protocol
MeOH was pre-cooled to –20°C prior to the incu-
bation of myocytes at room temperature for 5 min, 
which fixes and permeabilises the cell membrane [13].
Immunofluorescent labelling
After fixation and permeabilisation, immuno-
fluorescent labelling was performed as described 
previously [14]. After fixation and permeabilisation, 
myocytes were washed in 0.01 M PBS (pH 7.4) and 
blocked with 10% donkey serum in PBS. To prevent 
non-specific labelling, all primary and secondary 
Table 1. Immunolabelling detection of ion channels with 10% neutral buffered formalin (FA) or methanol (MeOH) fixation protocol
Kv1.5 Kv4.2 Cav1.2 Kir6.2 Nav1.5 Nav1.1
T ID S T ID S T ID S T ID S T ID S T ID S
FA fixation + – – + – – – – + + – – + + + + – +
MeOH fixation + + – + + – + – – – – – + + – + – +
+ presence of labelling; – absence of labelling; T — t-tubules; ID — intercalated discs; S — sarcolemma
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antibodies were diluted with PBS containing 1% BSA. 
Myocytes were incubated with primary IgGs at 4°C 
overnight and then incubated with secondary IgGs 
conjugated with FITC at room temperature for 1 h. 
Before and after incubation with secondary IgGs, 
the myocytes were washed with PBS. Finally, the 
myocytes were mounted with Vectashield mounting 
media (Vector Laboratories, Burlingame, CA), and 
the cover-slips were sealed with nail polish. Sample 
slides were stored in the dark at 4°C for up to 1 week 
before observation.
Observation with confocal microscopy
Immunofluorescent labelling of all proteins was 
visualised using laser scanning confocal microscopes 
(TCS SP [Leica Microsystems, Heidelberg, Germany], 
LSM 5 [Carl Zeiss, Oberkochen, Germany], or Radiance 
2100 MP Rainbow [Bio-Rad, Philadelphia, PA]: made 
available by the Division of Research Instrument and 
Equipment, Life Science Research Centre, Kagawa 
University) to detect FITC signals. Images were collec-
ted from a single optical slice through the centre of 
each myocyte. More than 10 cells were observed from 
3 hearts for each protein investigated and at least 
3 typical images (i.e., from 3 cells for each protein 
investigated) were saved for labelling analysis. No 
labelling was detectable without either the primary 
or secondary IgGs.
RESULTS AND DISCUSSION
Differences were found in terms of the expression 
pattern for ion channels with different fixation proto-
cols (Table 1). One example image, the immunolabel-
ling of the Kv1.5 channel, is shown in Figure 1. Kv1.5 
is responsible for the ultra-rapid delayed rectifier 
K+ current, IKur [10]. Kv1.5 labelling was detected as 
a transversely striated pattern with FA (Fig. 1A) and 
MeOH (Fig. 1B). In this study, the transversely striated 
labelling pattern corresponded to transverse tubules 
(t-tubules) probably because of the similar labelling 
pattern as the marker of t-tubules, a-actinin [15]. 
Kv1.5 labelling at the intercalated discs (IDs) was de-
tected with MeOH (Fig. 1B) but not with FA (Fig. 1A). 
The Kv1.5 channel has been shown to be located 
at the IDs of atrial cells when visualised with MeOH 
fixation [3]. Regarding other results using FA and 
MeOH fixation (Table 1), Kv4.2 at the IDs and Cav1.2 
at the t-tubules were not detected by FA but were 
detected by MeOH. Kv4.2 is responsible for transient 
outward K+ current, Ito [10]. Cav1.2 (a1C) is respon-
sible for L-type Ca2+ current, ICaL [10]. For Kv4.2, the 
labelling at the ID in myocytes with MeOH fixation 
in this study was similar to the one observed in 
a previous study in which 4% paraformaldehyde (PFA) 
was used as a fixative [1], but the labelling at the ID 
was not detected with 4% FA fixation in our study. 
In both atrial and ventricular myocytes fixed with 
2% PFA, Cav1.2 was detected at the sarcolemma as 
a transversely striated pattern by immunofluorescence 
labelling [9]. These differences in the labelling pattern 
may be due to differing FA concentrations or differing 
primary antibodies being used. Like Kv1.5 and Kv4.2 
at IDs and Cav1.2 labelling at t-tubules in the present 
results, if a particular protein is not detected using 
FA but is detected when MeOH is used, it is likely to 
be due to FA masking of the epitopes of antigens [6]. 
Figure 1. Images of immunolabelling of Kv1.5 in rat ventricular myocytes; A. Myocytes were fixed with 
10% neutral buffered formalin (FA) for 30 min at room temperature; B. Myocytes were fixed with pre-cooled 
methanol (MeOH) for 5 min at room temperature. Scale bar = 10 µm.
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Kir6.2 at the t-tubules and Nav1.5 at the sarcolem-
ma were detected by FA but not by MeOH (Table 1). 
Kir6.2 is responsible for the ATP-sensitive inwardly 
rectifying K+ current, IKATP [10]. Nav1.5 is responsi-
ble for the fast Na+ current, INa [10]. Nav1.5 on IDs 
was similar to those fixed with FA reported in earlier 
studies [8]. The heteromultimeric complexes of sul-
fonylurea receptors (SUR) and K+ inward rectifier (Kir) 
gene products were suggested to form sarcolemmal 
channels [11]; however, the subcellular localisation 
of Kir has rarely been found. In this study, Kir6.2 was 
only detected as possessing a transversely striated 
pattern. Like the case of Kir6.2 at the t-tubules and 
Nav1.5 at the sarcolemma in the present results, if 
a particular protein is not detected using MeOH but 
is detected using FA, this result is likely due to the 
effects of morphological alteration, such as altered 
antigen localisation in the cell membrane [13]. 
The fixation protocol was not affected to detect 
immnolabelling of Nav1.1 which is responsible for the 
slow Na+ current, INa [10] (Table 1). The labelling of 
Nav1.1 on t-tubules and the sarcolemma was similar 
to that in a previous study of fixation with FA [8].
CONCLUSIONS
Although FA alone has previously been used as 
a fixative for the immunofluorescent determination of 
the localisation of cytoskeletal ion channel proteins, it 
was shown to be insufficient from our observations. 
Therefore, we suggest that to optimise the detection 
of ion channels in cardiac cells by immunolabelling, 
both FA and MeOH fixation protocols should be used.
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